Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-12-02T22:31:26.516Z Has data issue: false hasContentIssue false

P-1304 - the Association Between Cannabis use and Suicidal Risk in Psychosis

Published online by Cambridge University Press:  15 April 2020

G. Serafini
Affiliation:
Neuroscience, Mental Health and Sensory Function, Sant’Andrea Hospital, Sapienza University of Rome, Rome, Italy
M. Pompili
Affiliation:
Neuroscience, Mental Health and Sensory Function, Sant’Andrea Hospital, Sapienza University of Rome, Rome, Italy Psychiatry, Harvard Medical School, Boston, NJ, USA
M. Innamorati
Affiliation:
Neuroscience, Mental Health and Sensory Function, Sant’Andrea Hospital, Sapienza University of Rome, Rome, Italy
P. Girardi
Affiliation:
Neuroscience, Mental Health and Sensory Function, Sant’Andrea Hospital, Sapienza University of Rome, Rome, Italy

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objectives

To critically review the current literature concerning the possible association between cannabis use and suicide behaviour in clinical (particularly in psychosis) and non clinical samples.

Methods

A detailed Pubmed/Medline, Scopus, PsycLit, and PsycInfo search to identify all papers and book chapters focusing on the association between cannabis use, and suicidal behaviour in psychosis during the period between 1980 and 2011 was performed.

Results

Most of studies reported a relevant association between suicidal behaviour and cannabis both in clinical and non clinical samples. However, there were also some studies suggesting a weak (not direct) association between cannabis and suicide. Those who attempt or complete suicide, either in clinical and non-clinical samples, are characterized by having other risk factors such as mood disorders, stressful life events, interpersonal problems, poor social support, lonely lives, and feelings of hopelessness. The association between cannabis use and suicidal behaviour in psychosis resulted still poor investigated. Limitations: It was not possible to perform a meta-analysis due to the excess in the heterogeneity of data. Also, although the effort to summarize the research in this field, the inclusion and exclusion of papers cited in this paper may reflect the authors’ choice.

Conclusions

Cannabis use was a relevant risk factor associated with both suicidal attempts and behaviours in clinical and non clinical samples. Therefore, preventive programs should be directed on reducing cannabis use in both clinical samples and general population. Evidence suggests that targeted suicide prevention programs can be also developed in specific at-risk subgroups.

Type
Abstract
Copyright
Copyright © European Psychiatric Association 2012
Submit a response

Comments

No Comments have been published for this article.